Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -1.962% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a O=C(COC(=O)c1cncc(Br)c1)NC1CCCCCC1
b O=C(CSc1nc2ccccc2n1CCc1ccccc1)NC1CCS(=O)(=O)C1
Answer: b. O=C(CSc1nc2ccccc2n1CCc1ccccc1)NC1CCS(=O)(=O)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CSc1nc2ccccc2n1CCc1ccccc1)NC1CCS(=O)(=O)C1
O=C(CSc1nc2ccccc2n1CCc1ccccc1)NC1CCS(=O)(=O)C1
N-(1,1-dioxothiolan-3-yl)-2-[1-(2-phenylethyl)benzimidazol-2-yl]sulfanylacetamide